• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Mercy’s AI-Powered Texting Platform Intercepts Chemo-Related Hospital Admissions

by Fred Pennic 11/15/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Jiajing Chen, Data Scientest

What You Should Know:

– Mercy has developed a new AI-driven texting platform called The Chen Chemotherapy Model, which is helping to keep chemotherapy patients out of the hospital by raising red flags before symptoms become severe. The model was created by Jiajing Chen, a data scientist who passed away from cancer earlier this year.

– The Chen Chemotherapy Model predicts the likelihood of outpatient chemotherapy patients experiencing symptoms that may result in hospitalization within 30 days of their chemotherapy treatment.

Chen Chemotherapy Model Integration with Smart Texting Platform

The Chen Chemotherapy Model is integrated into a smart texting platform that sends patients daily texts for seven days, except weekends and holidays. The text includes a list of symptoms including diarrhea, pain, fever, fatigue, nausea/vomiting, or no symptoms. When a patient selects a symptom, they are prompted to rate it and, based on their answers, the information may be escalated to their provider.

The Chen Chemotherapy Model has been shown to be effective at keeping patients out of the hospital. In a pilot study, the model was able to reduce hospitalizations by 20%. The new smart texting program using The Chen Chemotherapy Model is the first of many use cases made possible by the Mercy and Microsoft collaboration.

Jiajing Chen’s Legacy

Jiajing Chen passed away, but her project lives on as a legacy. Chen won Innovator of the Year at the 2020 ACCC National Oncology Conference for her work on the model, which has been improved with Epic workflow integration and texting technology. Chen Led an analytic work group at Mercy and contributed to FDA approvals for medical devices. Prior to joining Mercy, Chen was a faculty member at the Saint Louis University Department of Health and Clinical Outcomes Research. Her research interests included health and economic outcomes research associated with diabetes, cardiovascular disease, cancer and organ transplants.

“Jiajing always had a passion for medicine and for helping people,” said Andy Greenwood, Chen’s husband. “She was a medical student in China for a few years before coming to the U.S., then found herself in public health using her analytical and computer skills to help patients.”

“When she was in the hospital, she used all her strength to make sure her knowledge was passed along to her Mercy colleagues,” Greenwood said. “The project, named for Jiajing, will be a legacy I can share with our children, ages 1 and 4, to help them know their mother.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |